Dani Nazemian

Special Counsel

I help our clients design and implement compensation arrangements for executives and employees.

Dani Nazemian focuses her practice in the areas of executive compensation and employee benefits for public and private companies. She advises clients in public offerings on issues related to equity arrangements and other forms of executive compensation. She designs and implements equity and incentive compensation plans, employee stock purchase plans, employment agreements, severance and change in control plans and other compensation arrangements. She also assists public companies with the disclosure of compensation arrangements in public filings and advises on the impact of ISS and Glass Lewis in connection with compensation and corporate governance matters.

Download full bio 


  • Structure Therapeutics – $185.3 Million IPO 

  • Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion 

  • NeoPhotonics Agrees to Sell to Lumentum for $918 Million 

  • Flexion Therapeutics Agrees to Sell to Pacira BioSciences 

  • Jazz Pharmaceuticals Acquires Celator for $1.5 Billion 

  • View all

Practices & Industries



    Friends and family




  • Boston College Law School
    JD, cum laude, 2013

  • Johns Hopkins University
    MHS, 2008

  • University of California, Los Angeles
    BS, Psychobiology
    cum laude, 2007

Admissions & Credentials